However, the association of high IGFBP-3 expression with poor outcome in aggressive breast cancer [32, 35, 78] may, in addition to reflecting enhanced tumor growth as described above, reflect altered responsiveness to anticancer therapies. Here, IGFBP3 is linked to neoplasm.